In people with type 1 diabetes, the immune system mistakenly destroys the pancreatic beta cells responsible for producing insulin. Patients therefore require lifelong insulin therapy to regulate their blood glucose levels.
19 hours ago
0
2
Could AI hold the key to answering questions that have stumped doctors and scientists for decades? A recent study at Cold Spring Harbor Laboratory (CSHL) borrows concepts from machine learning to address an age-old riddle ...
19 hours ago
0
4
The human immune system has specialized cells called CD4 cytotoxic T lymphocytes (CD4 CTLs), which have been shown to kill tumor cells in some cancers. When a person gets sick, these cells multiply in a process called clonal ...
22 hours ago
0
257
Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders ...
22 hours ago
0
20
Age, genetics and lifestyle are known to influence how people respond to viral infections. Scientists also know that differences in immune responses play an important role, but exactly how these factors shape the course of ...
23 hours ago
0
4
As the immune system battles cancer, chronic stimulation gradually drives T cells to a state of exhaustion. But some of these exhausted T cells can lose expression of the exhaustion marker LAG3, move out of the tumor and ...
Aug 18, 2026
0
154
Crohn's disease, a condition characterized by widespread inflammation in the gut, may arise from a weakened immune response, according to new research from the University of Toronto's Temerty Faculty of Medicine.
Aug 18, 2026
0
13
Immunotherapy has transformed cancer treatment, yet many tumors remain stubbornly resistant to its effects. Among the most challenging are "cold tumors," including ovarian, breast and prostate cancers, which evade immune ...
Aug 18, 2026
0
3
Immune checkpoint inhibitors have revolutionized cancer treatment, yet many colorectal tumors remain resistant. Even among patients who initially respond, more than half eventually develop resistance, highlighting the need ...
Aug 18, 2026
0
2
A research group has revealed through studies in humans and mice that a subset of clear cell ovarian cancers, which have been considered difficult to treat with anticancer drugs and immunotherapy, responds to immunotherapy.
Aug 17, 2026
0
9
